United States · Series B startup

Who invested in Amira Pharmaceuticals

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

$25Mraised across 1 round since 2007, from 1 source

Latest round
Series B, $25MMar 2007
Investors
4
See who backed them

The rounds

  1. Mar 2007

The exit

ExitBuyerPriceWhen
AcquiredBristol-Myers Squibb$325MJul 2011

From historical deal records. Wrong? Tell us.

Everyone who backed them

Versant VenturesVC firm1round
Avalon VenturesVC firm1round
Novo Holdings A/SGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amira Pharmaceuticals

Who invested in Amira Pharmaceuticals?

Amira Pharmaceuticals's investors include Versant Ventures, Avalon Ventures, Novo Holdings A/S and Prospect Venture Partners.

How much has Amira Pharmaceuticals raised?

Amira Pharmaceuticals has raised $25M across 1 round since 2007.

When did Amira Pharmaceuticals last raise?

Amira Pharmaceuticals's most recent round was a Series B of $25M in Mar 2007.

What was Amira Pharmaceuticals's biggest round?

Its most recent round, $25M in Mar 2007, is also its largest on record.

Who backed Amira Pharmaceuticals first?

Amira Pharmaceuticals's first round on record, in Mar 2007, was backed by Versant Ventures, Avalon Ventures and Novo Holdings A/S and 1 others.

What stage is Amira Pharmaceuticals at?

Amira Pharmaceuticals's latest named round is a Series B, in Mar 2007.

Where is Amira Pharmaceuticals based?

Amira Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.